AMGN

Amgen Inc. · NASDAQ:AMGN

466.01 USD5.28 +1.15%

Amgen Inc. (NASDAQ:AMGN) last traded at 466.01 USD, up 1.15% on the day. Over the past year the stock is up 60.37%. Its 52-week range is 292.12 to 475.64. It is in the Health Technology sector (Biotechnology).

Key statistics

Open470.15

Day range465.33 – 475.64

52-week range292.12 – 475.64

Volume3.29 M

Average volume (10 days)2.57 M

Market cap251.94 B

P/E28.95

EPS (TTM)16.10

Dividend yield2.13%

Beta (1 year)0.1774

Revenue (TTM)38.20 B

Employees31.50 K

Performance

+4.86%1 week

+9.91%1 month

+21.99%3 months

+40.14%6 months

+41.74%Year to date

+60.37%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

405.32 USD

The average 1-year price target, −13.02% from the last price. See the forecast

Latest headlines

Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on CancerBenzinga · 29 Oct 2026
Amgen Q3 Earnings: Will Strong Drug Sales Offset Headwinds?Zacks · 28 Oct 2026
FDA warns Amgen over cancer drug promotional videoReuters · 28 Oct 2026
Amgen declares $2.52 dividendSeeking Alpha · 28 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.